Method of treating IL-10 deficiency

Details Method of treating IL-10 deficiency Method of treating IL-10 deficiency

2005-04-22

2008-10-07

Romeo, David (Department: 1647)

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

C424S085700, C424S085200

Reexamination Certificate

active

07431920

ABSTRACT:
A method for treating an IL-10 deficiency in a human subject is described, where a person having an IL-10 deficiency is identified and treated with interferon-tau (IFNτ) at a dose sufficient to increase the IL-10 level.

REFERENCES:
patent: H22 (1986-02-01), Creasey et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4752479 (1988-06-01), Briggs et al.
patent: 4766068 (1988-08-01), Oeda et al.
patent: 4769238 (1988-09-01), Rutter et al.
patent: 4822605 (1989-04-01), Powell
patent: 5098702 (1992-03-01), Zimmerman et al.
patent: 5128126 (1992-07-01), Boniver
patent: 5368854 (1994-11-01), Rennick
patent: 5376368 (1994-12-01), Ulich
patent: 5425940 (1995-06-01), Zimmerman et al.
patent: 5563126 (1996-10-01), Allen et al.
patent: 5632983 (1997-05-01), Hadden
patent: 5705363 (1998-01-01), Imakawa
patent: 5880114 (1999-03-01), Deluca et al.
patent: 5906816 (1999-05-01), Soos et al.
patent: 5942223 (1999-08-01), Bazer et al.
patent: 5958402 (1999-09-01), Bazer et al.
patent: 6036949 (2000-03-01), Richards et al.
patent: 6060450 (2000-05-01), Soos et al.
patent: 6080742 (2000-06-01), Germann et al.
patent: 6083919 (2000-07-01), Johnson et al.
patent: 6346243 (2002-02-01), Brod
patent: 6372206 (2002-04-01), Soos et al.
patent: 6403562 (2002-06-01), Johnson et al.
patent: 6528496 (2003-03-01), Allen et al.
patent: 6613354 (2003-09-01), Depui et al.
patent: 6699496 (2004-03-01), Kojima et al.
patent: 6942854 (2005-09-01), Soos et al.
patent: 7083782 (2006-08-01), Liu et al.
patent: 2002/0013452 (2002-01-01), Johnson et al.
patent: 2003/0012766 (2003-01-01), Soos et al.
patent: 2003/0017136 (2003-01-01), Cruz et al.
patent: 2003/0049277 (2003-03-01), Sokawa et al.
patent: 2003/0055013 (2003-03-01), Brass
patent: 2003/0086901 (2003-05-01), Cruz et al.
patent: 2003/0130486 (2003-07-01), Villarete et al.
patent: 2003/0185799 (2003-10-01), Rudolph
patent: 2003/0219405 (2003-11-01), Sokawa et al.
patent: 2003/0229044 (2003-12-01), Steinman et al.
patent: 2003/0232033 (2003-12-01), Cantrell
patent: 2004/0009896 (2004-01-01), Glynn et al.
patent: 2004/0013643 (2004-01-01), Mach
patent: 2004/0013695 (2004-01-01), Vande-Velde
patent: 2004/0086508 (2004-05-01), Skurkovich et al.
patent: 2004/0247565 (2004-12-01), Liu et al.
patent: 2005/0014734 (2005-01-01), Chang
patent: 2005/0265968 (2005-12-01), Liu et al.
patent: 0 814 831 (1998-01-01), None
patent: 1 114 998 (2001-07-01), None
patent: 1 241 242 (2002-09-01), None
patent: WO 90/09806 (1990-09-01), None
patent: WO 94/10313 (1994-05-01), None
patent: WO 96/28183 (1996-09-01), None
patent: WO 97/33607 (1997-09-01), None
patent: WO 02/06343 (2002-01-01), None
patent: WO 03/061728 (2003-07-01), None
patent: WO2005/087254 (2005-09-01), None
Petereit et al., Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis, 2003, Journal of the neurological sciences, vol. 206, pp. 209-214.
Abou Taleb et al.,The Journal of the Egyptian National Cancer, 12(1):59-64 (2000).
Alexenko et al.,J. Interferon Cytokine Res., 19:1335-1341 (1999).
Heeschen et al., Circulation, 107:2109-2114 (2003).
Van Roon et al.,The Journal of Rheumatology30(4):648-651 (2003).
Hugh McDevitt, “Specific Antigen Vaccination to Treat Autoimmune Disease” PNAS, 101(Suppl 2) 14627-14630 (2004).
White D., Fenner FJ “Medical Virology” Fourth Edition, Academic Press: New York, 1994.
Alexenko, A.P., et al.,Journal of Interferon and Cytokine Research17:769-779, (1997).
Bagaeva, L.V., et al.,Journal of Neuroimmunology137:109-116, (2003).
van Boxel-Dexaire, A.H.H., et al.,Ann Neurol45:695-703, (1999).
Brennan, F.R., et al.,J Med Microbiol41:20-28, (1994).
Brod, S.A., et al.,Journal of Neuroimmunology58:61-69, (1995).
Brod, S.A., et al.,Diabetologia41:1227-1232, (1998).
Brod, S.A.,Journal of Interferon and Cytokine Research19:841-852, (1999).
Carter, C.R.D., et al.,Clin Exp Immunol135:233-239, (2004).
Chaouat, G., et al.,J Immunology154(9):4261-4268, (1995).
Elices, M.J.,Current Opinion in Investigational Drugs4(11):1354-1362, (2003).
Filion, L.G., et al.,Clin Immunol106:127-138, (2003).
Groetzner, J., et al.,Transplantation77(4):568-574, (2004).
Kappos, L., et al.,J Neurol, 251(Suppl 5):V/57-V/64, (2004).
Khan, O.A., et al.,Mult Scler4(2):63-69, (1998).
Killestein, J. and Polman, C.H.,Curr Opin Neurol, 18:253-260, (2005).
Li, M.C. and He, S.H.,World Journal of Gastroenterology10:620-625, (2004).
Losy, J., et al.,Folia Neuropathol40(4):173-175, (2002).
Makhlouf, K., et al.,Journal of Neuroimmunology119:145-149, (2001).
Martin, J., et al.,Cytokine10(8):635-644, (1998).
Miller, D.H., et al.,N Engl J Med348:15-23, (2003).
Moldovan, I.R., et al.,Journal of Neuroimmunology141:132-140, (2003).
Mujtaba, M.G., et al.,J Neurol75(1-2):35-42, (1997).
Mujtaba, M.G., et al.,Cell Immunol186(2):94-102, (1998).
Nakajima, A., and Yoshihiro, S.,Journal of Interferon and Cytokine Research22:397-402, (2002).
Olek, M.J., et al.,Neurology56(Suppl 3):A76, (2001).
Petereit, H.F., et al.,Journal of Neurological Sciences206:209-214, (2003).
Pontzer, C.H., et al.,Biochemical and Biophysical Research Communications152(2):801-807, (1988).
Pontzer, C.H.,Cancer Research51:5304-5307, (1991).
van Roon, J., et al.,Journal of Rheumatology30:648-651, abstract only.
Sandborn, W.J. and Yednock, T.A.,American Journal of Gastroenterology98(11):2372-2382, (2003).
Soos, J.M., et al.,Journal of Interferon and Cytokine Research15:39-45, (1995).
Tuo, W., et al.,J Interferon and Cytokine Research19(2):179-187, (1999).
Tuohy, V.K., et al.,Journal of Neuroimmunology111:55-63, (2000).
Vanderhoff, B.T., and Tahboub, R.M.,Am Fam Physician66:273-280, (2002).
Asadullah, K., et al.,Pharmacol Rev55(2):241-269, (2003).
Fainardi, E., et al.,J of Neuroimmunology142:149-158, (2003).
Goldman, M. and Velu, T.,Advances in Nephrology24:79-90, (1995).
Jacobs, R., et al.,Rheumatology40:868-875, (2001).
Kozlowski, L., et al.,Annales Academiae Medicae Bialostocensis48:82-84, (2003).
Leon, L.R., et al.,Annals of the New York Academy of Sciences856:69-75, (1998).
Macdougall, I.C. and Cooper, A.C.,Nephrol Dial Transplant17(Supp 11):39-43, (2002).
Murray, H.W., et al.,Infection and Immunity70(11):6284-6293, (2002).
Rennick, D.M. and Fort, M.M.,Am J Physiol Gastrointest Liver Physiol278:G829-G833, (2000).
Soltys, J., et al.,J of Immunol168:1903-1910, (2002).
Soos, J.M., et al.,J Immunol169(5):2231-2235, (2002).
Soos, J.M., et al.,J of Neuroimmunology75:43-50, (1997).
Wang, B., et al.,J Immunol162:277-283, (1999).
Waubant, E., et al.,J of Neuroimmunology112:139-145, (2001).

Affiliated with

Also associated with

Rating

Method of treating IL-10 deficiency does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating IL-10 deficiency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating IL-10 deficiency will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4012394